
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MATH-1 CRISPR/Cas9 KO Plasmid (m) | sc-419230 | 20 µg | $397.00 |
Atoh1 (MATH-1) is a basic helix–loop–helix transcription factor that functions as a lineage-determining regulator during mouse development, driving neuronal and sensory cell differentiation programs. It integrates upstream morphogen and signaling cues, including Notch-mediated lateral inhibition and Wnt-associated patterning signals, to coordinate cell fate commitment and maturation. Atoh1 activity is critical for specification and maintenance of mechanosensory hair cells and multiple neuronal progenitor populations, linking it to pathways controlling proliferation-to-differentiation transitions. Dysregulated Atoh1 expression or function has been associated with altered neurodevelopmental trajectories and aberrant differentiation states relevant to disease modeling in tissues where Atoh1 governs progenitor competence.
MATH-1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Atoh1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Atoh1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Atoh1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MATH-1 protein expression.
This CRISPR knockout system enables efficient generation of Atoh1-deficient cell models for investigation of MATH-1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.